Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorpromazine for COVID-19
NCT04354805Phase 3Unknown
- Sponsor
- Cairo University
- Start
- Aug 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Aminazin in coronavirus disease 2019 (COVID-19), sponsored by Cairo University. Status: unknown.
02
Drugs
Aminazin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04354805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04354805.